FDA Offers Guidance On Safety Testing For Gene-Editing Tech
The U.S. Food and Drug Administration on Tuesday issued draft guidance recommending steps drug companies should take to evaluate the safety of gene-editing technology as they seek federal approval for cutting-edge...To view the full article, register now.
Already a subscriber? Click here to view full article